Any feedback?
Literature summary for 3.4.21.6 extracted from
- Determination of rivaroxaban - a novel, oral, direct Factor Xa inhibitor - in human plasma by high-performance liquid chromatography-tandem mass spectrometry (2008), J. Chromatogr. B, 872, 43-50.
Application
| Application | Comment | Organism |
|---|---|---|
| pharmacology | sensitive and specific quantification of inhibitor rivaroxaban in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Concentrations between 0.5 and 500 micrograms per liter can be detected. Inter-assay precision is below 7.4% and inter-assay accuracy is between 96.3% and 102.9% | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| rivaroxaban | sensitive and specific quantification in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Concentrations between 0.5 and 500 micrograms per liter can be detected. Inter-assay precision is below 7.4% and inter-assay accuracy is between 96.3% and 102.9% | Homo sapiens |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| blood plasma | - |
Homo sapiens | - |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
